Transcript
A (0:00)
Lobster, crab, shrimp, salmon, krill, even flamingos are pink because they consume it in the wild. Like people think farm raised salmon are dyed pink. They're actually fed astaxanthin just like they would get in the wild, but they just give it in their feed in the farm raised conditions. And so it's part of the diet. Naturally wild or farm raised.
B (0:22)
Okay, guys, got a guest today from Honolulu. Don't get too many guests from Hawaii, but we got Dave, founder of AX3Life, right here. And we're going to be talking longevity today and got some exciting studies that you were telling me about out there. And thanks for coming on, man.
A (0:37)
Oh, thanks for having me.
B (0:38)
Yeah. I guess we'll start off with the study we were just talking about. But you basically did a mice study, right?
A (0:43)
Well, we didn't, but we worked with the National Institutes of Health, so NIH and specifically the National Institute on Aging, which has a program called the itp, the Interventions Testing Program, which has been around for the last 20 or so years. And each year they have a cohort of mice that are specifically bred to test for longevity. Not your typical laboratory mice that are used for basic research. And they've tested things like rapamycin and metformin and resveratrol and NAD precursors, green tea, fish oil, et cetera. And in the last 20 years, only about 10 agents have extended lifespan at all, and. And only maybe five have extended lifespan more than 10%.
B (1:24)
Wow.
A (1:24)
And so we were selected for this program based on some really exciting research showing that this molecule called astaxanthin that we work with and have worked with for the last 25 years, that it extends lifespan in other model organisms like worms and fruit flies and yeast. And it impacts some of the important pathways that other longevity agents impact, like the sirtuins, mtor, et cetera, which are cellular pathways involved in longevity, that if you impact those, you have a promise to impact lifespan and healthspan. And we also did a study with our collaborators at the University of Hawaii showing that we increased Foxo 3, which is this anti aging gene that in humans, if you have the right version of this gene, you're more likely to live to 100 healthy. And so it turns out that we activated that gene in the mice and so that led the ITP program at the NIH to select us. So we supplied our material to the NIH back in 2019, and they followed these mice for a few years. And it turns out at the end of this that we did extend the lifespan of the mice by 12%, which is up there in the top five or so agents. Wow. But the big difference is that this molecule is exceptionally safe and well tolerated. It's something you could take every day as compared to something like rapamycin, which also was a superstar in this program and really put it on the map as a longevity agent many years ago because. Because rapamycin used to be a drug for like organ transplants. So it was repurposed and it turns out, wow, it extends lifespan, but it also has side effects and tolerability issues. And so a lot of people are trying to figure out, can I adjust the dosing or make different derivatives and ways to somehow get it in, but make it so it's not going to make your life uncomfortable taking it every day. But with astaxanthin, the molecule that we have in H3, that's something that's exceptionally safe, well tolerated. And so it's the perfect longevity agent because it's been shown to extend lifespan in this gold standard NIH study. But it also can promote health span because it impacts all these different areas of health, including cardiovascular health, brain health, joint and muscle health, you know, et cetera, eye health. So it's really the right package of impacting lifespan and health span. And so that's a study that you can't buy your way into something you have to be selected for by the program. And they conducted at three different institutions. Like normally a study might be conducted by one researcher or one team at one place. Yeah, they actually run this at three different sites. And the University of Michigan, the University of Texas, and another research institution in Maine. And they run it. So they run it in triplicate. So you basically have to work at all three sites in parallel over multiple years.
